Monthly
US$200
Billed every month
Sign in to subscribeSodium Valproate Sustained-release Tablets(I)
As of 13 November 2026, for Sodium Valproate Sustained-release Tablets(I), 5 applications are listed as under review at China's CDE; 2 companies have filed new generic applications in 2026; the chemical-drug catalogue lists 14 holders.
Companies, stages and changes, with each record available on this page.
Last 90 days: Accepted: 1 application
Current coverage may be incomplete
Which companies are listed, and at what stages?
Each source is counted separately. Expand a list to inspect companies, identifiers, dates and sources.
Legal reference identifiers are retained verbatim. Company labels use official English entries where available, or a visibly marked fixed romanization. Unverified drug names retain the Chinese source name with a No verified English name marker. Other Chinese free text is not displayed; use the source links or source-name columns in CSV exports.
Catalogue holders14View records ↓
Under-review filings5View records ↓
This year’s generic filers2View records ↓
NHSA approval numbers14View records ↓
API companies with A status16View records ↓
Chemical-drug catalogue
Loaded records: 14 holders; 0 in the quality-and-efficacy consistency-evaluation category, and 14 in the new chemical-registration-classification generic category. Category counts may overlap.
| Marketing authorization holder | Manufacturer | Approval number | Approved | Strength / specification | Catalogue category (source text) | View source |
|---|---|---|---|---|---|---|
| YaoPharma Co., Ltd. | YaoPharma Co., Ltd. | 国药准字H20265773 | 2026/09/02 | See source | Generic approved under the new chemical-drug registration classification | CDE |
| Nan Tong Lian Ya Pharma Co., Ltd. romanized | Nan Tong Lian Ya Pharma Co., Ltd. romanized | 国药准字H20265687 | 2026/08/25 | See source | Generic approved under the new chemical-drug registration classification | CDE |
| Shanghai An Bi Sheng Pharmaceutical Technology Co., Ltd. romanized | Jiangsu An Bi Sheng Pharmaceutical Co., Ltd. romanized | 国药准字H20265755 | 2026/08/25 | See source | Generic approved under the new chemical-drug registration classification | CDE |
| Sichuan Kelun Pharmaceutical Co., Ltd. | Sichuan Kelun Pharmaceutical Co., Ltd. | 国药准字H20265568 | 2026/08/04 | See source | Generic approved under the new chemical-drug registration classification | CDE |
| Jewim Pharmaceutical (Shandong) Co., Ltd. | Jewim Pharmaceutical (Shandong) Co., Ltd. | 国药准字H20265567 | 2026/08/04 | See source | Generic approved under the new chemical-drug registration classification | CDE |
| Jin Zhou Ao Hong Pharma Co., Ltd. romanized | Jin Zhou Ao Hong Pharma Co., Ltd. romanized | 国药准字H20265494 | 2026/08/04 | See source | Generic approved under the new chemical-drug registration classification | CDE |
| CISEN PHARMACEUTICAL CO., LTD. | CISEN PHARMACEUTICAL CO., LTD. | 国药准字H20265538 | 2026/08/04 | See source | Generic approved under the new chemical-drug registration classification | CDE |
| Shandong Zhong Health Qiao Pharmaceutical Co., Ltd. romanized | Shandong Zhong Health Qiao Pharmaceutical Co., Ltd. romanized | 国药准字H20265354 | 2026/07/28 | See source | Generic approved under the new chemical-drug registration classification | CDE |
| Zhejiang Apeloa Kangyu Pharmaceutical Co., Ltd. | Zhejiang Apeloa Kangyu Pharmaceutical Co., Ltd. | 国药准字H20264843 | 2026/06/17 | See source | Generic approved under the new chemical-drug registration classification | CDE |
| Huayi Pharmaceuticals (Anhui) Co., Ltd. | Huayi Pharmaceuticals (Anhui) Co., Ltd. | 国药准字H20264613 | 2026/06/03 | See source | Generic approved under the new chemical-drug registration classification | CDE |
| Sichuan Ke Rui De Pharmaceutical Co., Ltd. romanized | Sichuan Ke Rui De Pharmaceutical Co., Ltd. romanized | 国药准字H20263449 | 2026/02/25 | See source | Generic approved under the new chemical-drug registration classification | CDE |
| Hunan Sheng Xiang Zhong Pharmaceutical Co., Ltd. romanized | Hunan Sheng Xiang Zhong Pharmaceutical Co., Ltd. romanized | 国药准字H20249693 | 2024/12/06 | See source | Generic approved under the new chemical-drug registration classification | CDE |
| Beijing Foyou Pharma CO.,LTD | Beijing Foyou Pharma CO.,LTD | 国药准字H20244732 | 2024/08/27 | See source | Generic approved under the new chemical-drug registration classification | CDE |
| Ji Chuan Pharma Group Co., Ltd. romanized | Ji Chuan Pharma Group Co., Ltd. romanized | 国药准字H20266208 | 2026/10/13 | See source | Generic approved under the new chemical-drug registration classification | CDE |
Distinct full holder names; manufacturers are used only where the holder is unstated. The catalogue covers only part of the chemical-drug market. Categories are counted as recorded, not as a complete market census.
NHSA drug codes
Loaded records: 14 distinct approval numbers and 14 companies.
| Company / applicant | Approval number | Strength / specification | NHSA class | NHSA drug code | View source |
|---|---|---|---|---|---|
| Beijing Foyou Pharma CO.,LTD | 国药准字H20244732 | See source | Category B | XN03AGB231A010010100177 | NHSA |
| Xin Dong Sheng Ji Co., Ltd. romanized | 国药准字HC20181023 | See source | Category B | XN03AGB231A010010179160 | NHSA |
| Shanghai An Bi Sheng Pharmaceutical Technology Co., Ltd. romanized | 国药准字H20265755 | See source | Category B | XN03AGB231A010010182990 | NHSA |
| Hua Yi Pharma Technology (Anhui) Co., Ltd. romanized | 国药准字H20264613 | See source | Category B | XN03AGB231A010010184212 | NHSA |
| Xin Dong Sheng Ji Co., Ltd. romanized | 国药准字HC20181023 | See source | Category B | XN03AGB231A010010279160 | NHSA |
| Jin Zhou Ao Hong Pharma Co., Ltd. romanized | 国药准字H20265494 | See source | Category B | XN03AGB231A010010101190 | NHSA |
| Sichuan Kelun Pharmaceutical Co., Ltd. | 国药准字H20265568 | See source | Category B | XN03AGB231A010010102180 | NHSA |
| Sichuan Ke Rui De Pharmaceutical Co., Ltd. romanized | 国药准字H20263449 | See source | Category B | XN03AGB231A010010102181 | NHSA |
| Shandong Zhong Health Qiao Pharmaceutical Co., Ltd. romanized | 国药准字H20265354 | See source | Category B | XN03AGB231A010010104066 | NHSA |
| Jewim Pharmaceutical (Shandong) Co., Ltd. | 国药准字H20265567 | See source | Category B | XN03AGB231A010010104111 | NHSA |
| CISEN PHARMACEUTICAL CO., LTD. | 国药准字H20265538 | See source | Category B | XN03AGB231A010010104127 | NHSA |
| Sai Nuo Fei (Hangzhou) Pharmaceutical Co., Ltd. romanized | 国药准字H20010595 | See source | Category B | XN03AGB231A010010104502 | NHSA |
| Zhejiang Apeloa Kangyu Pharmaceutical Co., Ltd. | 国药准字H20264843 | See source | Category B | XN03AGB231A010010104685 | NHSA |
| Hua Run Shuang He Xiang Zhong Pharma (Hunan) Co., Ltd. romanized | 国药准字H20249693 | See source | Category B | XN03AGB231A010010104971 | NHSA |
| Nan Tong Lian Ya Pharma Co., Ltd. romanized | 国药准字H20265687 | See source | Category B | XN03AGB231A010010183802 | NHSA |
| Shandong Zhong Health Qiao Pharmaceutical Co., Ltd. romanized | 国药准字H20265354 | See source | Category B | XN03AGB231A010010204066 | NHSA |
| CISEN PHARMACEUTICAL CO., LTD. | 国药准字H20265538 | See source | Category B | XN03AGB231A010010204127 | NHSA |
| CISEN PHARMACEUTICAL CO., LTD. | 国药准字H20265538 | See source | Category B | XN03AGB231A010010304127 | NHSA |
| CISEN PHARMACEUTICAL CO., LTD. | 国药准字H20265538 | See source | Category B | XN03AGB231A010010404127 | NHSA |
| CISEN PHARMACEUTICAL CO., LTD. | 国药准字H20265538 | See source | Category B | XN03AGB231A010010504127 | NHSA |
| CISEN PHARMACEUTICAL CO., LTD. | 国药准字H20265538 | See source | Category B | XN03AGB231A010010604127 | NHSA |
| CISEN PHARMACEUTICAL CO., LTD. | 国药准字H20265538 | See source | Category B | XN03AGB231A010010704127 | NHSA |
| CISEN PHARMACEUTICAL CO., LTD. | 国药准字H20265538 | See source | Category B | XN03AGB231A010010804127 | NHSA |
| CISEN PHARMACEUTICAL CO., LTD. | 国药准字H20265538 | See source | Category B | XN03AGB231A010010904127 | NHSA |
Approval numbers and companies are deduplicated separately; packaging records remain individually listed. An empty insurance class means it is unstated. NHSA codes supply no approval date and do not establish the outcome of an acceptance number.
Current under-review applications
Loaded records: 5 filings and 5 distinct first applicants.
Generic 4 · Supplement 1
| Company / applicant | Acceptance number | Application type | Accepted | Strength / specification | View source |
|---|---|---|---|---|---|
| Nanjing Ze Heng Pharmaceuticals Technology Kai Fa Co., Ltd. romanized; Jiangsu Ya Bang Ai Pu Sen Pharma Co., Ltd. romanized | CYHS2600912 | Generic | 2026/04/21 | Not stated by source | CDE |
| Zhejiang Zhong Yan Pharmaceuticals Technology Co., Ltd. romanized; Zhejiang Nord Pharmaceutical Co., Ltd | CYHB2601686 | Supplement | 2026/09/04 | Not stated by source | CDE |
| Zhejiang Nord Pharmaceutical Co., Ltd | CYHS2400289 | Generic | 2024/01/20 | Not stated by source | CDE |
| Ran Dian (Nanjing) Biopharmaceuticals Technology Co., Ltd. romanized; ZHEJIANG JINGXIN PHARMACEUTICAL CO.，LTD. | CYHS2600212 | Generic | 2026/01/20 | Not stated by source | CDE |
| Hebei Chen Guang Tong Cheng Pharmaceutical Co., Ltd. romanized; Yi Ling Wan Zhou International Pharmaceutical Co., Ltd. romanized | CYHS2504200 | Generic | 2025/12/06 | Not stated by source | CDE |
New generic filings in 2026
Loaded records: 2 filings and 2 distinct first applicants.
| Company / applicant | Acceptance number | Application type | Accepted | Strength / specification | View source |
|---|---|---|---|---|---|
| Nanjing Ze Heng Pharmaceuticals Technology Kai Fa Co., Ltd. romanized; Jiangsu Ya Bang Ai Pu Sen Pharma Co., Ltd. romanized | CYHS2600912 | Generic | 2026/04/21 | Not stated by source | CDE |
| Ran Dian (Nanjing) Biopharmaceuticals Technology Co., Ltd. romanized; ZHEJIANG JINGXIN PHARMACEUTICAL CO.，LTD. | CYHS2600212 | Generic | 2026/01/20 | Not stated by source | CDE |
API registrations
Non-component matches: 16 companies with A status and 6 I-status records. Component matches are listed separately and excluded from these counts.
| Name | Company / applicant | Registration number | Status | Name match | Source update date | View source |
|---|---|---|---|---|---|---|
| 丙戊酸 · No verified English name | Sun Pharmaceutical Industries Limited | Y20250001033 | I | Salt-normalized ingredient | 2025/09/25 | CDE |
| 丙戊酸 · No verified English name | Sun Pharmaceutical Industries Limited | Y20250000649 | I | Salt-normalized ingredient | 2025/08/18 | CDE |
| 丙戊酸 · No verified English name | Ren He Tang Pharma Co., Ltd. romanized | Y20240000643 | A | Salt-normalized ingredient | 2026/10/14 | CDE |
| 丙戊酸 · No verified English name | Hebei Chen Guang Tong Cheng Pharmaceutical Co., Ltd. romanized | Y20240000641 | A | Salt-normalized ingredient | 2026/03/26 | CDE |
| 丙戊酸 · No verified English name | Lu Zhou Ke Rui De Pharmaceutical Co., Ltd. romanized | Y20240000705 | A | Salt-normalized ingredient | 2026/06/10 | CDE |
| 丙戊酸 · No verified English name | Zhejiang Sai Mo Pharmaceutical Co., Ltd. romanized | Y20240000376 | A | Salt-normalized ingredient | 2025/12/05 | CDE |
| 丙戊酸钠 · No verified English name | Hebei Chen Guang Tong Cheng Pharmaceutical Co., Ltd. romanized | Y20240000434 | A | Exact ingredient | 2025/12/05 | CDE |
| 丙戊酸钠 · No verified English name | Anhui Yue Kang Kai Yue Pharmaceutical Co., Ltd. romanized | Y20240000228 | A | Exact ingredient | 2025/09/15 | CDE |
| 丙戊酸 · No verified English name | Sun Pharmaceutical Industries Ltd. | Y20220001212 | I | Salt-normalized ingredient | 2025/05/20 | CDE |
| 丙戊酸 · No verified English name | SCI PHARMTECH, INC. TAOYUAN PLANT | Y20230000276 | A | Salt-normalized ingredient | 2026/07/14 | CDE |
| 丙戊酸钠 · No verified English name | Beijing Foyou Pharma CO.,LTD | Y20230000085 | A | Exact ingredient | 2024/06/07 | CDE |
| 丙戊酸钠 · No verified English name | Hua Run Shuang He Xiang Zhong Pharma (Hunan) Co., Ltd. romanized | Y20220001291 | A | Exact ingredient | 2026/07/09 | CDE |
| 丙戊酸 · No verified English name | Beijing Foyou Pharma CO.,LTD | Y20220001239 | A | Salt-normalized ingredient | 2026/05/20 | CDE |
| 丙戊酸钠 · No verified English name | Anjan Drug Private Limited | Y20220000905 | A | Exact ingredient | 2025/06/26 | CDE |
| 丙戊酸 · No verified English name | Hua Run Shuang He Xiang Zhong Pharma (Hunan) Co., Ltd. romanized | Y20220000968 | A | Salt-normalized ingredient | 2026/07/09 | CDE |
| 丙戊酸 · No verified English name | Anjan Drug Private Limited | Y20220000132 | A | Salt-normalized ingredient | 2026/11/08 | CDE |
| 丙戊酸钠 · No verified English name | Liaoning Yao Lian Pharmaceutical Co., Ltd. romanized | Y20210000551 | A | Exact ingredient | 2023/07/28 | CDE |
| 丙戊酸钠 · No verified English name | SANOFI WINTHROP INDUSTRIE | Y20190009129 | A | Exact ingredient | 2024/09/27 | CDE |
| 丙戊酸钠 · No verified English name | Hunan Di Nuo Pharmaceutical Co., Ltd. romanized | Y20190006806 | A | Exact ingredient | — | CDE |
| 丙戊酸钠 · No verified English name | Lu Zhou Ke Rui De Pharmaceutical Co., Ltd. romanized | Y20190006765 | A | Exact ingredient | 2026/06/10 | CDE |
| 丙戊酸钠 · No verified English name | Shanghai Qing Ping Pharma Co., Ltd. romanized | Y20190005803 | A | Exact ingredient | — | CDE |
| 丙戊酸镁 · No verified English name | Hunan Di Nuo Pharmaceutical Co., Ltd. romanized | Y20190004825 | A | Salt-normalized ingredient | — | CDE |
| 丙戊酸钠 · No verified English name | Jiangsu Heng Rui Pharmaceuticals Co., Ltd. romanized | Y20190004684 | A | Exact ingredient | 2025/08/01 | CDE |
| 丙戊酸钠 · No verified English name | Hua Run Shuang He Xiang Zhong Pharma (Hunan) Co., Ltd. romanized | Y20190002767 | A | Exact ingredient | 2026/07/09 | CDE |
| 丙戊酸镁 · No verified English name | Hua Run Shuang He Xiang Zhong Pharma (Hunan) Co., Ltd. romanized | Y20190002766 | A | Salt-normalized ingredient | 2026/07/09 | CDE |
| 丙戊酸钠 · No verified English name | Ren He Tang Pharma Co., Ltd. romanized | Y20190002082 | A | Exact ingredient | 2025/05/16 | CDE |
| 丙戊酸钠 · No verified English name | Shandong Fang Ming Pharma Group Co., Ltd. romanized | Y20190001586 | A | Exact ingredient | 2024/09/27 | CDE |
| 丙戊酸 · No verified English name | Xu Fu Pharmaceutical Technology Co., Ltd. Tao Yuan Factory romanized | Y20190000512 | I | Salt-normalized ingredient | 2023/03/15 | CDE |
| 丙戊酸钠 · No verified English name | SANOFI CHIMIE | Y20170001920 | I | Exact ingredient | — | CDE |
| 丙戊酸钠 · No verified English name | SCI Pharmtech, Inc. | Y20170000790 | A | Exact ingredient | 2026/02/02 | CDE |
| 丙戊酸钠 · No verified English name | Sun Pharmaceutical Industries Limited | Y20260000650 | I | Exact ingredient | 2026/10/30 | CDE |
A/I are source statuses. Matching uses exact ingredients, salt-normalized names and maintained combination components, without fuzzy matching. A-status companies are deduplicated by the first registered company. Components are excluded from headline counts; the register does not identify the associated formulation.
What changed recently?
Last 90 days, ordered by fact date. Marketing approvals, trial registrations, supplements, notices and review changes are labelled separately.
Trial registration does not mean an application will follow.
This product is outside the trial-registration backfill scope. New registrations after daily collection started remain in scope. Historical rows may also be found by another product search; neither implies complete historical coverage for this product.
NHSA edition maintained to 2026-10-23; latest successful catalogue check: 2026/11/13 06:39. NHSA records lack approval dates; only an earlier edition or observation establishes precedence.
This source was last successfully updated at 2026/11/12 18:32; current coverage may be incomplete.
-
2026/09/04Accepted
Zhejiang Zhong Yan Pharmaceuticals Technology Co., Ltd. romanized; Zhejiang Nord Pharmaceutical Co., Ltd
CYHB2601686
Fact date: 2026/09/04 · Site observation date: 2026/10/21
View source ↗
How current is each source?
- CDE acceptances and review
- Last successful update: 2026/11/13 06:42
- Chemical-drug catalogue
- Last successful update: 2026/11/13 06:39
Distinct full holder names; manufacturers are used only where the holder is unstated. The catalogue covers only part of the chemical-drug market. Categories are counted as recorded, not as a complete market census.
- Full API register
- Last successful update: 2026/11/13 06:41
- NHSA drug codes
- Last successful update: 2026/11/05 06:45
The fully loaded edition was maintained to 2026-10-23. Publication lags maintenance: the verified 2026-10-16 edition was published on 10-28, a 12-day gap. This is not a fixed lag for every edition.
- NMPA drug delivery notices
- Last successful update: 2026/11/12 18:32 · Current coverage may be incomplete
First index-page publication dates: 2026-10-29 to 2026-11-13; 2 pages pending. Covers loaded notices only, not a complete historical approval database.
- Drug Clinical Trial Registry and Information Disclosure Platform
- Last successful update: 2026/11/13 08:09 · Current coverage may be incomplete
Daily collection reads new registrations. Backfill covers registration numbers from 2025 onward (CTR2025/CTR2026), not first-publication years. States are dated observations; revisions are not tracked.
This product is outside the trial-registration backfill scope. New registrations after daily collection started remain in scope. Historical rows may also be found by another product search; neither implies complete historical coverage for this product.
Public-product searches scanned: 7/30; discovered pending details: 13. Record counts in unscanned portions remain unknown.
Filings are counted by acceptance number and filing companies by first applicant. Strengths may have separate applications. Drug names are normalized only for width and whitespace; distinct generic names, dosage forms and combinations remain separate. Unstated strengths are marked. Company counts from different sources must not be added together.
Fact dates are approval dates, acceptance dates, trial first-publication dates or complete-snapshot observation dates, as applicable. Publication and site-observation dates are separate. Historical backfills are not current-period new events. Exit records cover currently inactive applications with an identifiable complete snapshot, not a full review history.
Free follow
Follow changes to Sodium Valproate Sustained-release Tablets(I)
Up to 3 drugs per email address, in one weekly digest. Starts after email confirmation; unsubscribe at any time.
Subscriptions
Next-day facts and deliverable timelines
- One email the next day when new facts are collected for your followed products.
- Export the complete loaded event timeline for each followed product as CSV.
- Add up to 4 additional recipients, each confirmed by email.
- Increase your follow limit from 3 to 10 products.
Quarterly
US$540
Billed every three months
US$180 per month
Sign in to subscribeYearly
US$1,920
Billed every year
US$160 per month
Sign in to subscribeNeed more than 10 followed products or more than 5 recipients? Contact us.
Separate one-time purchase
US Orange Book × China records comparison
Full table and CSV export for 12 months from payment, with monthly data updates. No automatic renewal.
Subscriptions and comparison-table access are purchased separately. Neither includes the other.
Billed by Creem, our merchant of record · Terms · Refund policy